---
schema_version: "secwatch.filing_event.v1"
accession: "0001588978-25-000041"
form_type: "8-K"
ticker: "PRCT"
cik: "0001588978"
company_name: "PROCEPT BioRobotics Corp"
filed_at: "2025-08-06T23:59:59+00:00"
generated_at: "2026-05-17T19:27:57.160072+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# PROCEPT Q2 revenue $79.2M (+48% YoY); raises FY25 guidance; appoints new CEO

## Summary
- Q2 total revenue $79.2M, up 48% YoY; U.S. handpiece/consumables $43.1M (+58%).
- Net loss improved to $19.6M from $25.6M; Adjusted EBITDA loss $8.0M (vs. $17.9M loss prior year).
- Gross margin expanded to 65% from 59% due to operational efficiencies and higher system ASP.
- Raises FY 2025 revenue guidance to $325.5M (45% growth) from prior $323.0M; expects 64.5% gross margin.
- Appoints Larry Wood as CEO effective Sept. 2, 2025; brings 40 years medtech leadership.

## SEC filing metadata
- accession: 0001588978-25-000041
- form_type: 8-K
- ticker: PRCT
- cik: 0001588978
- company_name: PROCEPT BioRobotics Corp
- filed_at: 2025-08-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1588978/000158897825000041/0001588978-25-000041-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1588978/000158897825000041/prct-20250806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001588978-25-000041
- JSON: https://secwatch.observer/filing/0001588978-25-000041.json
- Plain text: https://secwatch.observer/filing/0001588978-25-000041.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.